SK

Shibban Krishen Ganju

Active Director Director DIN 01966923
DIN 01966923 First appointment Aug 2006 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Aug 2006
Shareholding value •••• Premium profile

About Shibban Krishen Ganju

Data last updated:

Shibban Krishen Ganju is a Director at Atrimed Pharmaceuticals Private Limited (since 2010), Director at Mahila Healthcare Private Limited (since 2020) and Designated Partner at Damle & Ganju Health Consultants Llp (since 2020). The companies operate in Healthcare, Events and Entertainment and Agriculture. The largest current company by reported revenue is Atrimed Pharmaceuticals Private Limited at ₹24.09 Cr (FY 2024). Earlier, Shibban Krishen Ganju was an Additional Director at Goodwill Auctions & Experiences Private Limited (2016–2025) and Director at Moksha-Yug Access India Private Limited (2006–2008) and 2 more.

DIN 01966923
Primary Designation Director
Industry Healthcare
First Appointment 18 Aug 2006
Oldest Company Age 23 yrs
Largest company Atrimed Pharmaceuticals Private Limited · ₹24.09 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Mar 20102003₹24.09 Cr (FY 2024)Active
Mahila Healthcare Private Limited U85110KA2020PTC131850
Director23 Jan 20202020Active
Designated Partner13 Jan 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director20 Oct 20162016₹86.9 Lakh (FY 2017)Under Process Of Striking Off
Director18 Aug 20062005₹8,398 (FY 2021)Active
C Square Healthcare Private Limited U85191KA2013PTC070244
Additional Director06 Mar 20182013₹71.91 Cr (FY 2025)Active
Director16 Jun 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Shibban Krishen Ganju

Directorship timeline

Open interactive timeline →
Damle & Ganju Health Consultants Llp
Mahila Healthcare Private Limited
Atrimed Pharmaceuticals Private Limited
Chicago India Health Infrastructure Private Limited
Premium access

Shareholding and investment profile for Shibban Krishen Ganju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shibban Krishen Ganju

Shibban Krishen Ganju currently holds 3 directorships: Atrimed Pharmaceuticals Private Limited (Director, since 25 Mar 2010, revenue ₹24.09 Cr (FY 2024)); Mahila Healthcare Private Limited (Director, since 23 Jan 2020); Damle & Ganju Health Consultants Llp (Designated Partner, since 13 Jan 2020).

Shibban Krishen Ganju was first appointed on 18 Aug 2006 as Director at Moksha-Yug Access India Private Limited. The most recent appointment on record is 23 Jan 2020 at Mahila Healthcare Private Limited.

Shibban Krishen Ganju held 4 earlier board appointments: Goodwill Auctions & Experiences Private Limited (Additional Director, 20 Oct 2016 to 01 Jul 2025); Moksha-Yug Access India Private Limited (Director, 18 Aug 2006 to 23 Feb 2008); C Square Healthcare Private Limited (Additional Director, 06 Mar 2018 to 18 Jun 2018); Chicago India Health Infrastructure Private Limited (Director, from 16 Jun 2010).

The current boards of Shibban Krishen Ganju's companies include Hrishikesh Damle (Atrimed Pharmaceuticals Private Limited), Latha Damle (Atrimed Pharmaceuticals Private Limited), Rishi Ganju (Atrimed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available